Skip to main
OHI
OHI logo

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc is increasing its 2025 funds from operations (FFO) estimates to $2.81 per share, reflecting a positive trend driven by higher investment volume. Additionally, the normalized FFO estimate for 2025 has been raised to $2.95 per share, indicating robust operational performance when excluding non-recurring items. The stock has demonstrated strong performance, with a year-to-date increase of 12%, significantly outperforming its sector benchmark, and is trading near the upper limit of its 10-year valuation range, suggesting favorable market positioning.

Bears say

Omega Healthcare Investors Inc. faces significant headwinds due to ongoing challenges experienced by its operators, which raises concerns regarding the stability and profitability of its core business in the long-term healthcare sector. Despite a slight increase in the 2026 adjusted funds from operations (AFFO) estimate to $3.22 per share, this does not sufficiently mitigate worries related to the company's relative valuation and market positioning. Overall, the persistent operator challenges suggest a cautious outlook, indicating potential risks to Omega's future financial performance and growth prospects.

OHI has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 8 analysts, OHI has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.